Literature DB >> 23105742

Serum homocysteine levels in cerebrovascular accidents.

Zolianthanga Zongte1, L Shaini, Asis Debbarma, Th Bhimo Singh, S Bilasini Devi, W Gyaneshwar Singh.   

Abstract

Hyperhomocysteinemia has been considered an independent risk factor in the development of stroke. The present study was undertaken to evaluate serum homocysteine levels in patients with cerebrovascular accidents among the Manipuri population and to compare with the normal cases. Ninety-three cerebrovascular accident cases admitted in the hospital were enrolled for the study and twenty-seven age and sex matched individuals free from cerebrovascular diseases were taken as control group. Serum homocysteine levels were estimated by ELISA method using Axis homocysteine EIA kit manufactured by Ranbaxy Diagnostic Ltd. India. The finding suggests that hyperhomocysteinemia is associated with cerebrovascular accident with male preponderance, which increases with advancing age. However, whether hyperhomocysteinemia is the cause or the result of cerebrovascular accidents needs further investigations.

Entities:  

Keywords:  Cerebrovascular accident; Homocysteine; Hyperhomocysteinemia

Year:  2008        PMID： 23105742      PMCID： PMC3453082          DOI： 10.1007/s12291-008-0034-2

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN： 0970-1915


  15 in total

1.  The increase of plasma homocysteine concentrations with age is partly due to the deterioration of renal function as determined by plasma cystatin C.

Authors:  L Norlund; A Grubb; G Fex; H Leksell; J E Nilsson; H Schenck; B Hultberg
Journal:  Clin Chem Lab Med       Date:  1998-03       Impact factor: 3.694

2.  Enzyme conversion immunoassay for determining total homocysteine in plasma or serum.

Authors:  F Frantzen; A L Faaren; I Alfheim; A K Nordhei
Journal:  Clin Chem       Date:  1998-02       Impact factor: 8.327

3.  Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease.

Authors:  David Tanne; Moti Haim; Uri Goldbourt; Valentina Boyko; Ram Doolman; Yehuda Adler; Daniel Brunner; Solomon Behar; Ben-Ami Sela
Journal:  Stroke       Date:  2003-02-20       Impact factor: 7.914

4.  Quantitative determination of serum triglycerides by the use of enzymes.

Authors:  G Bucolo; H David
Journal:  Clin Chem       Date:  1973-05       Impact factor: 8.327

Review 5.  Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment.

Authors:  L Brattström; B Israelsson; B Norrving; D Bergqvist; J Thörne; B Hultberg; A Hamfelt
Journal:  Atherosclerosis       Date:  1990-02       Impact factor: 5.162

6.  Enzymatic determinations of cholesterol in high-density-lipoprotein fractions prepared by a precipitation technique.

Authors:  B W Steele; D F Koehler; M M Azar; T P Blaszkowski; K Kuba; M E Dempsey
Journal:  Clin Chem       Date:  1976-01       Impact factor: 8.327

7.  Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke.

Authors:  J W Eikelboom; G J Hankey; S S Anand; E Lofthouse; N Staples; R I Baker
Journal:  Stroke       Date:  2000-05       Impact factor: 7.914

8.  Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke.

Authors:  P J Lindsberg; O Carpén; A Paetau; M L Karjalainen-Lindsberg; M Kaste
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

9.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

Authors:  C J Boushey; S A Beresford; G S Omenn; A G Motulsky
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

10.  Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders.

Authors: 
Journal:  Stroke       Date:  1989-10       Impact factor: 7.914
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.